PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1984 May; 77(5): 406–409.
PMCID: PMC1439908

Determination of progestational potency: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (578K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bradley DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. [PubMed]
  • Dickey RP. Reply to paper by Dr. Edgren on "progestational potency of oral contraceptives: a polemic". Int J Fertil. 1978;23(3):170–174. [PubMed]
  • Dickey RP, Stone SC. Progestational potency of oral contraceptives. Obstet Gynecol. 1976 Jan;47(1):106–112. [PubMed]
  • Edgren RA. Progestational potency of oral contraceptives: a polemic. Int J Fertil. 1978;23(3):162–169. [PubMed]
  • GREENBLATT RB, JUNGCK EC, BARFIELD WE. A new test for efficacy of progestational compounds. Ann N Y Acad Sci. 1958 Jul 30;71(5):717–721. [PubMed]
  • Meade TW, Greenberg G, Thompson SG. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J. 1980 May 10;280(6224):1157–1161. [PMC free article] [PubMed]
  • Meade TW, Haines AP, North WR, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet. 1977 Nov 5;2(8045):948–951. [PubMed]
  • Pike MC, Henderson BE, Krailo MD, Duke A, Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. [PubMed]
  • Swyer GI. Potency of progestogens in oral contraceptives--further delay of menses data. Contraception. 1982 Jul;26(1):23–27. [PubMed]
  • SWYER GI, LITTLE V. Actions and uses of orally active progestational steroids. Proc R Soc Med. 1962 Oct;55:861–863. [PubMed]
  • Swyer GI, Little V. Clinical assessment of relative potency of progestagens. J Reprod Fertil Suppl. 1968 Dec;5(Suppl):63–68. [PubMed]
  • SWYER GI, SEBOK L, BARNS DF. Determination of the relative potency of some progestogens in the human. Proc R Soc Med. 1960 Jun;53:435–436. [PMC free article] [PubMed]
  • Weir RJ, Briggs E, Mack A, Naismith L, Taylor L, Wilson E. Blood pressure in women taking oral contraceptives. Br Med J. 1974 Mar 23;1(5907):533–535. [PMC free article] [PubMed]
  • Whitehead MI, Townsend PT, Pryse-Davies J, Ryder TA, King RJ. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 1981 Dec 31;305(27):1599–1605. [PubMed]
  • Wynn V, Adams PW, Godsland I, Melrose J, Niththyananthan R, Oakley NW, Seed M. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet. 1979 May 19;1(8125):1045–1049. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press